Mydekla 60mg Tablet (Daclatasvir)
Medicine OverView
Mydekla 60mg Tablet (Daclatasvir) is an antiviral medicine used in the treatment of chronic Hepatitis C Virus (HCV) infection. It contains Daclatasvir 60mg, a direct-acting antiviral agent that helps block the multiplication and spread of the Hepatitis C virus inside the body.
Daclatasvir works by targeting specific viral proteins required for the replication of HCV. By inhibiting viral growth, Mydekla 60mg Tablet helps reduce viral load, support liver health, and improve long-term treatment outcomes in patients with chronic hepatitis C infection.
Mydekla 60mg Tablet is commonly prescribed in combination with other antiviral medicines as part of genotype-specific HCV treatment protocols under specialist supervision.
This medicine should only be used under the guidance of qualified healthcare professionals experienced in hepatitis management.
Mydekla 60mg Tablet is used for the treatment and management of chronic Hepatitis C infection.
Doctors prescribe Mydekla 60mg Tablet as part of a complete antiviral treatment regimen depending on HCV genotype and liver condition.
Mydekla 60mg Tablet contains Daclatasvir, a direct-acting antiviral medicine.
Daclatasvir works by:
By reducing viral activity, Mydekla 60mg Tablet helps improve treatment response and supports better liver health outcomes.
Mydekla 60mg Tablet provides several important benefits in chronic Hepatitis C treatment.
Proper Hepatitis C treatment is important for protecting liver function and reducing long-term complications associated with chronic viral infection.
Hepatitis C is a viral infection that primarily affects the liver. Chronic infection can gradually damage liver tissue and may lead to liver complications if untreated.
Common symptoms of chronic Hepatitis C may include:
Antiviral therapy helps reduce viral replication and supports liver health in patients with chronic HCV infection.
The dosage of Mydekla 60mg Tablet depends on:
Important usage instructions:
Strict adherence to antiviral therapy improves treatment success and viral suppression outcomes.
Like all antiviral medicines, Mydekla 60mg Tablet may cause side effects in some patients.
Seek immediate medical attention if you experience:
Regular liver function monitoring may be required during treatment.
Before using Mydekla 60mg Tablet, inform your doctor if you have:
Regular blood tests and liver function monitoring may be required during antiviral therapy.
Do not discontinue treatment without medical advice.
Mydekla 60mg Tablet may interact with several medicines.
Always inform your healthcare provider about all medicines, supplements, and herbal products you are using.
Pregnancy: Use during pregnancy only if specifically advised by a healthcare professional.
Breastfeeding: Consult your doctor before using Mydekla 60mg Tablet while breastfeeding.
Always discuss treatment risks and benefits before starting therapy.
Mydekla 60mg Tablet is used for the treatment of chronic Hepatitis C Virus (HCV) infection.
It contains Daclatasvir 60mg.
It works by blocking Hepatitis C viral replication and reducing viral load.
Many eligible patients may achieve sustained viral response with proper antiviral treatment under specialist supervision.
Regular treatment helps reduce viral replication, protect liver function, and improve long-term health outcomes.
Yes, Mydekla 60mg Tablet should only be used under specialist medical supervision with a valid prescription.
You can buy Mydekla 60mg Tablet (Daclatasvir) online from a licensed pharmacy with a valid prescription. Always purchase antiviral medicines from trusted suppliers to ensure product authenticity, quality, and proper storage conditions.
Before purchasing online:
What do you think about this product?